Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2017 16:04 ET | Source: Aptose Biosciences, Inc.

OHSU and Aptose Present CG’806 Preclinical Data at ASH 59th Annual Meeting

PORTLAND, Ore. and SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- The OHSU Knight Cancer Institute and Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced the presentation of preclinical...
December 11, 2017 16:04 ET | Source: Aptose Biosciences, Inc.

Aptose Presents New Preclinical Data on CG’806 pan-FLT3/pan-BTK Inhibitor at ASH 59th Annual Meeting

SAN DIEGO and TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced the presentation of preclinical data from research led by The University of...
November 14, 2017 16:00 ET | Source: Aptose Biosciences, Inc.

Aptose Reports Results for the Third Quarter Ended September 30, 2017

SAN DIEGO and TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated...
November 07, 2017 08:00 ET | Source: Aptose Biosciences, Inc.

Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017

SAN DIEGO and TORONTO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting...
November 01, 2017 11:14 ET | Source: Aptose Biosciences, Inc.

Aptose to Present New CG’806 Data at the 2017 ASH Annual Meeting

SAN DIEGO and TORONTO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO), (TSX:APS), a clinical-stage company developing highly differentiated...
October 30, 2017 08:00 ET | Source: Aptose Biosciences, Inc.

Aptose Enters into $15.5 Million Common Shares Purchase Agreement with Aspire Capital Fund, LLC

SAN DIEGO and TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated...
September 19, 2017 08:02 ET | Source: Aptose Biosciences Inc.

Aptose to Present at the 17th Annual Biotech in Europe Forum

SAN DIEGO, and TORONTO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the...
September 12, 2017 08:00 ET | Source: Aptose Biosciences Inc.

Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806

SAN DIEGO and TORONTO and SEOUL, South Korea, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing...
September 05, 2017 08:30 ET | Source: Aptose Biosciences Inc.

Aptose Biosciences to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

SAN DIEGO and TORONTO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the...
August 08, 2017 16:05 ET | Source: Aptose Biosciences Inc.

Aptose Reports Results for the Second Quarter Ended June 30, 2017

SAN DIEGO and TORONTO, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated...